The simultaneous departure of the Chairman and CFO creates uncertainty in leadership, though the immediate appointment of a new CFO mitigates some operational risk. Monitor for any subsequent 8-K filings regarding a new Chairman or any material changes to the company's financial reporting or strategy.
Price Chart
Executive Summary
Raphael Pharmaceutical Inc. filed an 8-K reporting the voluntary resignations of Chairman Ajay Kumar Dhadha (effective June 30, 2026) and CFO/General Counsel/Director Guy Ofir (effective July 16, 2026). The company appointed Uri Tadelis as the new CFO effective July 16, 2026. Both resignations were stated as not resulting from any disagreement with the company. The departure of the CFO and Chairman, while voluntary, represents a significant leadership vacuum at a small OTC-listed pharmaceutical company, though a replacement CFO was named immediately.
Key Facts
- Chairman Ajay Kumar Dhadha resigned effective June 30, 2026.
- CFO, General Counsel, and Director Guy Ofir resigned effective July 16, 2026.
- Uri Tadelis was appointed as CFO effective July 16, 2026.
- Both resignations were voluntary and not due to any disagreement with the company.
- No replacement for the Chairman was announced.
Financial Impact
No financial figures reported in the filing.
Risk Factors
- Leadership vacuum with no Chairman replacement named
- Potential disruption to financial reporting and corporate governance
- Small OTC-listed company with limited resources may struggle to attract qualified board members
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-078937 |
| Document: 0001213900-26-078937-index-headers.html | 0001213900-26-078937 |
| Document: 0001213900-26-078937-index.html | 0001213900-26-078937 |
| Document: 0001213900-26-078937.txt | 0001213900-26-078937 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 8w ago | 8-K | $1.40 $1.40 | · 0.00% | ▼ −1.18% | $1.51 (+7.86%) |
Jul 17, 2026 14w ago | 8-K | $1.40 $1.40 | · 0.00% | ▼ −4.45% | $1.51 (+7.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers